Selenium and anticarcinogenesis: underlying mechanisms
- PMID: 18827575
- DOI: 10.1097/MCO.0b013e3283139674
Selenium and anticarcinogenesis: underlying mechanisms
Abstract
Purpose of review: To discuss recent research related to anticarcinogenic mechanisms of selenium action in light of the underlying chemical/biochemical functions of the selenium species, likely to be executors of those effects.
Recent findings: Recent studies in a variety of model systems have increased the understanding of the anticarcinogenic mechanisms of selenium compounds. These include effects on gene expression, DNA damage and repair, signaling pathways, regulation of cell cycle and apoptosis, metastasis and angiogenesis. These effects would appear to be related to the production of reactive oxygen species produced by the redox cycling, modification of protein-thiols and methionine mimicry. Three principle selenium metabolites appear to execute these effects: hydrogen selenide, methylselenol and selenomethionine. The fact that various selenium compounds can be metabolized to one or more of these species but differ in anticarcinogenic activity indicates competing pathways of their metabolic and chemical/biochemical disposition. Increasing knowledge of selenoprotein polymorphisms has shown that at least some are related to cancer risk and may affect carcinogenesis indirectly by influencing selenium metabolism.
Summary: The anticarcinogenic effects of selenium compounds constitute intermediate mechanisms with several underlying chemical/biochemical mechanisms such as redox cycling, alteration of protein-thiol redox status and methionine mimicry.
Similar articles
-
Selenium compounds regulate p53 by common and distinctive mechanisms.Anticancer Res. 2004 May-Jun;24(3a):1401-8. Anticancer Res. 2004. PMID: 15274301
-
Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids.Biochem Pharmacol. 2004 Feb 1;67(3):547-54. doi: 10.1016/j.bcp.2003.09.004. Biochem Pharmacol. 2004. PMID: 15037206
-
Apoptotic cellular events for selenium compounds involved in cancer prevention.J Bioenerg Biomembr. 2007 Feb;39(1):91-8. doi: 10.1007/s10863-006-9065-7. J Bioenerg Biomembr. 2007. PMID: 17549643
-
Selenium: from cancer prevention to DNA damage.Toxicology. 2006 Oct 3;227(1-2):1-14. doi: 10.1016/j.tox.2006.07.017. Epub 2006 Jul 25. Toxicology. 2006. PMID: 16935405 Review.
-
Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion.J Nutr Biochem. 2008 Jan;19(1):1-7. doi: 10.1016/j.jnutbio.2007.02.005. Epub 2007 Jun 27. J Nutr Biochem. 2008. PMID: 17588734 Review.
Cited by
-
Role of selenium-containing proteins in T-cell and macrophage function.Proc Nutr Soc. 2010 Aug;69(3):300-10. doi: 10.1017/S002966511000176X. Epub 2010 Jun 25. Proc Nutr Soc. 2010. PMID: 20576203 Free PMC article.
-
Methyl selenocysteine: single-dose pharmacokinetics in men.Cancer Prev Res (Phila). 2011 Nov;4(11):1938-44. doi: 10.1158/1940-6207.CAPR-10-0259. Epub 2011 Aug 16. Cancer Prev Res (Phila). 2011. PMID: 21846796 Free PMC article. Clinical Trial.
-
Sodium selenide toxicity is mediated by O2-dependent DNA breaks.PLoS One. 2012;7(5):e36343. doi: 10.1371/journal.pone.0036343. Epub 2012 May 7. PLoS One. 2012. PMID: 22586468 Free PMC article.
-
Pancreatic cancer risk and levels of trace elements.Gut. 2012 Nov;61(11):1583-8. doi: 10.1136/gutjnl-2011-301086. Epub 2011 Dec 19. Gut. 2012. PMID: 22184070 Free PMC article.
-
Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice.Nutrients. 2018 Sep 27;10(10):1380. doi: 10.3390/nu10101380. Nutrients. 2018. PMID: 30262787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
